We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+3.67%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$22.8B
AUM Growth
-$4.8M
Cap. Flow
+$69.6M
Cap. Flow %
0.31%
Top 10 Hldgs %
39.53%
Holding
188
New
24
Increased
37
Reduced
34
Closed
37

Top Sells

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$508M
2
CRM icon
Salesforce
CRM
+$266M
3
NOW icon
ServiceNow
NOW
+$264M
4
SPGI icon
S&P Global
SPGI
+$246M
5
SHW icon
Sherwin-Williams
SHW
+$212M

Sector Composition

Rank Sector Weight
1 Healthcare 33.98%
2 Technology 14.71%
3 Financials 12.17%
4 Communication Services 7.05%
5 Industrials 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMLX icon
151
Amylyx Pharmaceuticals
AMLX
$4.31B
-1,150,221
Closed -$3.73M
ANAB icon
152
AnaptysBio
ANAB
$1.71B
-183,876
Closed -$6.16M
ASND icon
153
Ascendis Pharma A/S
ASND
$16.6B
-1,400
Closed -$209K
BEKE icon
154
KE Holdings
BEKE
$19.6B
-4,740,833
Closed -$94.4M
BYND icon
155
Beyond Meat
BYND
$254M
-633
Closed -$129K
CNC icon
156
Centene
CNC
$32.1B
-614,917
Closed -$46.3M
CYTK icon
157
Cytokinetics
CYTK
$10.7B
-102,400
Closed -$5.41M
HWM icon
158
Howmet Aerospace
HWM
$108B
-1,514,339
Closed -$152M
IWM icon
159
PUT
iShares Russell 2000 ETF
IWM
$81.9B
-1,000,000
Closed -$221M
LU icon
160
Lufax Holding
LU
$1.2B
-15,000
Closed -$52.4K
NOW icon
161
ServiceNow
NOW
$133B
-1,475,250
Closed -$264M
PCVX icon
162
Vaxcyte
PCVX
$9.32B
-28,000
Closed -$3.2M
RARE icon
163
Ultragenyx Pharmaceutical
RARE
$2.55B
-4,000
Closed -$222K
RGTIW icon
164
Rigetti Computing Warrants
RGTIW
$178M
-22,675
Closed -$2.08K
RNAM
165
DELISTED
Avidity Biosciences
RNAM
-5,000
Closed -$230K
SHW icon
166
Sherwin-Williams
SHW
$84.1B
-555,950
Closed -$212M
SPGI icon
167
S&P Global
SPGI
$127B
-475,334
Closed -$246M
TAL icon
168
TAL Education Group
TAL
$6.28B
-1,365,000
Closed -$16.2M
THC icon
169
Tenet Healthcare
THC
$22.6B
-692,442
Closed -$115M
TMDX icon
170
Transmedics
TMDX
$3.29B
-44,000
Closed -$6.91M
VTYX
171
DELISTED
Ventyx Biosciences
VTYX
-3,170,000
Closed -$6.91M
MGX icon
172
Metagenomi Therapeutics
MGX
$46.5M
-1,057,201
Closed -$2.29M
CTLT
173
DELISTED
CATALENT, INC.
CTLT
-8,394,000
Closed -$508M
GHIXW
174
DELISTED
Gores Holdings IX, Inc. Warrant
GHIXW
-166,664
Closed -$14.6K
IVCP
175
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
-300,000
Closed -$3.31M

Similar funds

Thomas Steyer's Q4 2024 Portfolio in Review

As of Q4 2024, Thomas Steyer held 188 positions worth $22.8B, down 0.02% from $22.8B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Thomas Steyer's Q4 2024 filing shows 24 new, 37 increased, 34 reduced and 37 closed positions. Its largest new stake was Autodesk: 1,841,800 shares worth $544M. The largest sale was CATALENT, INC., an estimated $508M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Thomas Steyer's largest Q4 2024 buy was Autodesk: 1,841,800 shares worth $544M.
  • Thomas Steyer added most to Discover Financial Services in Q4 2024, an estimated $580M increase.
  • Thomas Steyer's biggest Q4 2024 reduction was Salesforce, cutting an estimated $266M.
  • Thomas Steyer fully exited CATALENT, INC. in Q4 2024, selling an estimated $508M.
  • Thomas Steyer's ten largest holdings make up 40% of its $22.8B portfolio in Q4 2024.
  • Thomas Steyer opened 24 new positions and closed 37 in Q4 2024.
  • Thomas Steyer's portfolio value fell 0.02% quarter-over-quarter to $22.8B.

Based on Farallon Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.